DJIA 18,040.37 29.69 0.16%
NASDAQ 5,082.93 12.90 0.25%
S&P 500 2,111.73 4.34 0.21%
market minute promo

Verastem, Inc. (NASDAQ: VSTM)

8.59 -0.06 (-0.69%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

VSTM $8.59 -0.69%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $8.74
Previous Close $8.65
Daily Range $8.36 - $8.85
52-Week Range $6.78 - $12.35
Market Cap $313.9M
P/E Ratio -4.28
Dividend (Yield) $0.00 (0.0%)
Volume 340,980
Average Daily Volume 347,573
Current FY EPS -$1.77




Drug Makers

Verastem, Inc. (VSTM) Description

Verastem Inc is a biopharmaceutical company focused on discovering and developing proprietary small molecule drugs targeting cancer stem cells along with proprietary companion diagnostics. Website:

News & Commentary Rss Feed

Did Researchers Just Discover the Cause of Pancreatic Cancer?

Pancreatic cancer is the fourth-leading cause of cancer-related death, but researchers may have moved one step closer to discovering a cure this past week.

Verastem (VSTM) Shares March Higher, Can It Continue? - Tale of the Tape

Verastem (VSTM) Shares March Higher, Can It Continue? - Tale of the Tape

Find the Best Stocks to Invest in with This No. 1 Buy Signal

Novartis, Verastem & Cepheid Making Biotech Headlines On Friday

3 Biotech Stocks You Won't Want To Miss In 2015

Thursday 1/29 Insider Buying Report: VSTM, OKSB

The Absurdity of Flex Pharma IPO: 2 Spices and a Veg Net $86M

Recent Offering Provides Great Opportunity To Buy Verastem Before Significant 2015 Catalysts

3 Biotech IPOs Debuting This Week

5 Biotech Secondaries Traders Are Watching

See More VSTM News...